{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-042546","form_type":"8-K","ticker":"MGRX","cik":"0001938046","company_name":"MANGOCEUTICALS, INC.","filed_at":"2024-10-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.387712+00:00","generated_at":"2026-05-30T10:09:31.551915+00:00","sec_items":["3.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Mangoceuticals issues 33,333 shares under ELOC and converts 200 Series B shares into 93,299 common shares","bullets":["Sold 33,333 shares at $2.36 each for net proceeds of $78,787 under the $25M ELOC with Platinum Point Capital.","Converted 200 Series B Preferred shares into 93,299 common shares at $2.358/share, value $220,000.","Both issuances exempt from registration under Securities Act (Section 4(a)(2)/Rule 506 and Section 3(a)(9)).","Resale of shares under ELOC and conversion are covered by effective registration statements."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-042546","json":"https://secwatch.observer/filing/0001493152-24-042546.json","markdown":"https://secwatch.observer/filing/0001493152-24-042546.md","text":"https://secwatch.observer/filing/0001493152-24-042546.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1938046/000149315224042546/0001493152-24-042546-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1938046/000149315224042546/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T10:09:31.551915+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}